Welcome to Novo Nordisk in the United States

print email
Latest News
Nov 1, 2018

Sales decreased by 2% in Danish kroner and increased by 4% in local currencies to USD 13.2 billion. • Sales of Victoza® increased by 6% to USD 2.9 billion (12% in local currencies). • Sales...

Oct 31, 2018

Bagsværd, Denmark, 31 October 2018 ­– Novo Nordisk today announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights to Macrilen™ (macimorelin),...

Oct 22, 2018

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved an updated label for Saxenda® (liraglutide) injection 3 mg. The label now includes some data from the...

Aug 8, 2018

Sales decreased by 5% in Danish kroner and increased by 4% in local currencies to USD 8.8 billion. • Sales of Victoza® increased by 2% to USD 1.9 billion (12% in local currencies). • Sales of...

Download Center

Visit the download center to download Novo Nordisk video and more

Stay Connected

Sign up to receive our new alerts
via e-mail